Phosphonate

Global Osteoporosis Drugs Market by Route of Administration, Drug Class and Region - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 6, 2020
Health, Pharmaceutical, Hormones, Organ systems, RTT, Progonadotropins, Bisphosphonate, Selective estrogen receptor modulators, Phenols, Osteoporosis, Chemical compounds, Phosphonate, Medication related osteonecrosis of the jaw, Aromatase inhibitor

The "Global Osteoporosis Drugs Market By Route of Administration, By Drug Class, By Region, Industry Analysis and Forecast, 2020-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Osteoporosis Drugs Market By Route of Administration, By Drug Class, By Region, Industry Analysis and Forecast, 2020-2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Osteoporosis Drugs Market size is expected to reach $10.9 billion by 2026, rising at a market growth of 4.4% CAGR during the forecast period.
  • Many of the drugs on the market include selective estrogen inhibitor modulator (SERM) bisphosphonates, parathyroid hormone treatment, calcitonin, and RANK ligand inhibitors.
  • Bisphosphonates are a type of drug used to reduce deterioration of the bone structure and to treat osteoporosis and related diseases.

Despite Several Factors Supporting Osteoporosis Drugs Market, Patent Expiration of Blockbuster Drugs to Hamper Market's Progress: TMR

Retrieved on: 
Tuesday, March 10, 2020
Osteopathies, Osteoporosis, RTT, Organ systems, Bisphosphonate, Phosphonate

Some of the key insights from global osteoporosis drugs market study are mentioned below:

Key Points: 
  • Some of the key insights from global osteoporosis drugs market study are mentioned below:
    Bisphosphonates segment under drug class category is expected to dominate the global osteoporosis drugs market.
  • This in turn shall help the players of global osteoporosis drugs market to have better growth opportunities and a brighter future in the global osteoporosis drugs market from 2019 to 2027.
  • The presence of these players is making it difficult for new players to enter the global osteoporosis drugs market.
  • With the help of these resource, the new players can avail a sustainable future in the global osteoporosis drugs market.

Despite Several Factors Supporting Osteoporosis Drugs Market, Patent Expiration of Blockbuster Drugs to Hamper Market's Progress: TMR

Retrieved on: 
Tuesday, March 10, 2020
Osteopathies, Osteoporosis, RTT, Organ systems, Bisphosphonate, Phosphonate

Some of the key insights from global osteoporosis drugs market study are mentioned below:

Key Points: 
  • Some of the key insights from global osteoporosis drugs market study are mentioned below:
    Bisphosphonates segment under drug class category is expected to dominate the global osteoporosis drugs market.
  • This in turn shall help the players of global osteoporosis drugs market to have better growth opportunities and a brighter future in the global osteoporosis drugs market from 2019 to 2027.
  • The presence of these players is making it difficult for new players to enter the global osteoporosis drugs market.
  • With the help of these resource, the new players can avail a sustainable future in the global osteoporosis drugs market.

Global Osteoporosis Therapeutics Industry Insights, 2012-2025 - Bisphosphonates Will Bring in Healthy Gains of >$6.9 Billion by 2025

Retrieved on: 
Monday, March 9, 2020
RTT, Osteopathies, Osteoporosis, Bisphosphonate, Phosphonate

DUBLIN, March 9, 2020 /PRNewswire/ -- The "Osteoporosis Therapeutics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 9, 2020 /PRNewswire/ -- The "Osteoporosis Therapeutics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Osteoporosis Therapeutics market worldwide is projected to grow by US$2.5 Billion, driven by a compounded growth of 3%.
  • Bisphosphonates, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.2%.
  • Poised to reach over US$6.9 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.

Osteoporosis Therapeutics Market Analysis, Trends, and Forecasts, 2025 - Worldwide Market is Projected to Grow by US$2.5 Billion - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 18, 2019
Health, Pharmaceutical, RTT, Bisphosphonate, Osteoporosis, Phosphonate

Osteoporosis Therapeutics market worldwide is projected to grow by US$2.5 Billion, driven by a compounded growth of 3%

Key Points: 
  • Osteoporosis Therapeutics market worldwide is projected to grow by US$2.5 Billion, driven by a compounded growth of 3%
    Bisphosphonates, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.2%.
  • The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market.
  • Poised to reach over US$6.9 Billion by the year 2025, Bisphosphonates will bring in healthy gains adding significant momentum to global growth.
  • In Japan, Bisphosphonates will reach a market size of US$1.3 Billion by the close of the analysis period.

Chelating Agent Market in APAC to witness 4%+ growth to 2024

Retrieved on: 
Thursday, August 9, 2018
Chemistry, Chelating agents, Ethylenediaminetetraacetic acid, Chelation, Phosphonate

Increasing paper demand from the flexible packaging industry will contribute to pulp & paper sector which in turn will boost the chelating agent market in the coming years.

Key Points: 
  • Increasing paper demand from the flexible packaging industry will contribute to pulp & paper sector which in turn will boost the chelating agent market in the coming years.
  • Rising water treatment industry will also be a driving factor for the chelating agent market due to its applicability as a water treatment chemical.
  • Environmental and health hazards linked with petrochemical based chelating agents like EDTA and HEDP may pose a challenge to the overall chelating agent market.
  • Asia Pacific is anticipated to occupy the largest share of chelating agent market with growth rate of around 4% CAGR during the forecast period.